These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 37333810)

  • 21. Molecular Subtypes Based on Cuproptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Colorectal Cancer.
    Huang H; Long Z; Xie Y; Qin P; Kuang L; Li X; Zhao Y; Zhang X; Yang L; Ma W; Xiao X; Liu Y; Sun X; Zhang M; Wang F; Hu D; Hu F
    J Oncol; 2022; 2022():5034092. PubMed ID: 36276275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crosstalk of cuproptosis-related subtypes, establishment of a prognostic signature, and immune infiltration characteristics in gastric cancer.
    Wang Y; Guo F; Song W; Guo W; Shao J; Liu Y
    Heliyon; 2024 Jan; 10(2):e24411. PubMed ID: 38298669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma.
    Tang X; Ren X; Huang T; Miao Y; Ha W; Li Z; Yang L; Mi D
    Mediators Inflamm; 2023; 2023():3951940. PubMed ID: 37124062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma.
    Chen X; Sun M; Feng W; Chen J; Ji X; Xie M; Huang W; Chen X; Zhang B; Nie Y; Fan D; Wu K; Xia L
    Front Genet; 2023; 14():1056000. PubMed ID: 36845390
    [No Abstract]   [Full Text] [Related]  

  • 25. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Subtypes Defined by Cuproptosis-Associated Genes, Prognostic Model Development, and Tumor Immune Microenvironment Characterization in Adrenocortical Carcinoma.
    Huang Q; Huang XY; Xue YT; Wu XH; Wu YP; Ke ZB; Kang Z; Xu YC; Chen DN; Wei Y; Xue XY; Huang ZY; Xu N
    J Inflamm Res; 2024; 17():7017-7036. PubMed ID: 39377045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell.
    Sun Y; Yao L; Man C; Gao Z; He R; Fan Y
    Front Immunol; 2023; 14():1220760. PubMed ID: 37822927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma.
    Li Y; Zeng X
    Front Pharmacol; 2022; 13():1081952. PubMed ID: 36703728
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma.
    Chen X; Hu G; Xiong L; Xu Q
    Pathol Oncol Res; 2022; 28():1610558. PubMed ID: 36213162
    [No Abstract]   [Full Text] [Related]  

  • 32. Cuproptosis-related molecular patterns and gene (ATP7A) in hepatocellular carcinoma and their relationships with tumor immune microenvironment and clinical features.
    Li S; Weng J; Xiao C; Lu J; Cao W; Song F; He Z; Zhang P; Zhu Z; Xu J
    Cancer Rep (Hoboken); 2023 Dec; 6(12):e1904. PubMed ID: 37885090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The characterization of tumor microenvironment infiltration and the construction of predictive index based on cuproptosis-related gene in primary lung adenocarcinoma.
    Li K; Wu LL; Wang H; Cheng H; Zhuo HM; Hao Y; Liu ZY; Li CW; Qian JY; Li ZX; Xie D; Chen C
    Front Oncol; 2022; 12():1011568. PubMed ID: 36505852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma.
    Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A
    Front Oncol; 2022; 12():941156. PubMed ID: 36505813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel cuproptosis-related gene signature predicting overall survival in pediatric neuroblastoma patients.
    Yang H; Yang J; Bian H; Wang X
    Front Pediatr; 2022; 10():1049858. PubMed ID: 36568423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer.
    Sha S; Si L; Wu X; Chen Y; Xiong H; Xu Y; Liu W; Mei H; Wang T; Li M
    Front Immunol; 2022; 13():922780. PubMed ID: 35979353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive analysis of cuproptosis-related genes in immune infiltration and prognosis in lung adenocarcinoma.
    Xiaona X; Liu Q; Zhou X; Liang R; Yang S; Xu M; Zhao H; Li C; Chen Y; Xueding C
    Comput Biol Med; 2023 May; 158():106831. PubMed ID: 37037146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Cuproptosis-Related Subtypes, Establishment of a Prognostic Signature and Characterization of the Tumor Microenvironment in Gastric Cancer.
    Li J; Kong C; Song W; Fu T
    Int J Gen Med; 2023; 16():1631-1652. PubMed ID: 37168531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.
    Huang Y; Gong P; Su L; Zhang M
    Sci Rep; 2023 Nov; 13(1):20870. PubMed ID: 38012210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.